Categories

The biomedical innovation now happening in the molecular diagnostics industry is making it possible for clinicians to answer their patients’ four…

Continue Reading

Mental Health Month, Depression and GeneSight®    The GeneSight® genetic test has produced exciting news for patients diagnosed with depression.  A landmark…

Continue Reading

ColonCancerPoster_Thumbnail

In hereditary colon cancer, knowledge is power!  During the month of March, Myriad Genetics is demonstrating a strong commitment to preventing hereditary colon…

Continue Reading

The U.S. Food and Drug Administration (FDA) has approved BRACAnalysis CDx® for use as a companion diagnostic to identify patients with HER2- metastatic…

Continue Reading

It is estimated that 19 million people suffer from “year round” depression. If every American with depression lived in one state…

Continue Reading

Shortly after I was born, my father was diagnosed with Hodgkin’s lymphoma and he passed away when he was just 29…

Continue Reading

When diagnosed with prostate cancer, genetic precision can guide decisions between patients and their doctors. Click below to learn more and…

Continue Reading

Nothing is more personal than an individual’s DNA fingerprint.  At Myriad, we honor our legal and ethical responsibility to protect patients’…

Continue Reading

BioEYES Logo

Myriad Genetics was proud to support Project BioEYES and help deliver STEM (science, technology, engineering, and mathematics) education to K-12 students…

Continue Reading

June is Men’s Health Month and it’s important to help generate awareness on education for early detection of Men’s health issues, such as…

Continue Reading